Peter J. Barry

Statistics

Publications

Citations

453

H-Index

Active since

1964

Affiliations

Manchester University NHS Foundation Trust(Current)

Queen's University Belfast

Institute of Public Health of Serbia

St. Vincent's University Hospital

Université Paris Cité

Peter J. Barry is an author at Manchester University NHS Foundation Trust specializing in cystic fibrosis, ivacaftor therapy, and cystic fibrosis pharmacotherapy.

Publications per year

1964–2023

Publications

Triple Therapy for Cystic Fibrosis <i>Phe508del</i> –Gating and –Residual Function Genotypes

Peter J. Barry, Marcus Mall, Antonio Álvarez et al. · New England Journal of Medicine · 2021 · 275 citations · Full text

Life Sciences, Genetics, Pharmacotherapy +16

CFTR activity is enhanced by the novel corrector GLPG2222, given with and without ivacaftor in two randomized trials

Scott C. Bell, Peter J. Barry, K. De Boeck et al. · Journal of Cystic Fibrosis · 2019 · 53 citations · Full text

Life Sciences, Molecular Biology, Pharmacotherapy +13

Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study

Patrick A. Flume, Reta Fischer Biner, D.G. Downey et al. · The Lancet Respiratory Medicine · 2021 · 51 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Chorioretinal and Choriovitreal Neovascularization After Photocoagulation for Proliferative Diabetic Retinopathy

I. H. L. Wallow, Karla J. Johns, Peter J. Barry et al. · Ophthalmology · 1985 · 27 citations

Medicine, Ophthalmology, Vision Science +14

GIANT RETINAL TEAR IN USHER SYNDROME TYPE II

Mark Cahill, Peter J. Barry, Paul F. Kenna · Retina · 1998 · 13 citations

Medicine, Ophthalmology, Surgery +10

1–5 of 8